Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Erratum for: 61Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of 61Cu-labeled PET Radiotracers.
Journal: Radiology
Published: July 28, 2026
61Cu-NODAGA Prostate-specific Membrane Antigen Imaging and Therapy for Prostate Cancer: Phase 1 Trial of a New Class of 61Cu-labeled PET Radiotracers.
Journal: Radiology
Published: December 09, 2025
High PSMA Avidity, Yet Still Benign: The Importance of CT Morphology for Diagnosing Fibrous Dysplasia on PSMA-Targeted PET/CT.
Journal: Clinical nuclear medicine
Published: January 24, 2025
Dosimetry of [177Lu]Lu-DOTATATE in Patients with Advanced Midgut Neuroendocrine Tumors: Results from a Substudy of the Phase III NETTER-1 Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 30, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Journal: British journal of haematology
Published: February 05, 2024
CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition.
Journal: Leukemia
Published: March 07, 2023
The Quest for an Accurate Functional Tumor Volume with 68Ga-DOTATATE PET/CT.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 01, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026